At the IGTP TODAY
The Germans Trias i Pujol Research Institute (IGTP) has participated in a ground-breaking event to bring art and science together for European Performing Science Night with results that left nobody indifferent. The Fundació Èpica la Fura dels Baus led the project which involved artists and scientists from the IGTP and four international universities.
Next weekend Badalona will be the site of European Performance Science Night 2021, an activity within the framework of the European Researchers' Night, financed by the Marie Sklodowska-Curie Actions (MSCA). The Germans Trias i Pujol Research Institute (IGTP) has joined forces with one of the projects within this initiative led by the Épica Foundation La Fura dels Baus (a world-famous Catalan theatre company), with the aim of bringing science to the citizen and motivating young people to take up scientific careers
A total of 23 researchers have taken part in the first event of the European project European Performing Science Night (EPSN) part of European Researcher's Night a European public event that brings scientists and society together. All three research groups on the camps taking part in the project participated in the workshop.
Badalona will be one of the locations to feature in the European Researchers' Night. The research team led by the Èpica Foundation of the Fura dels Baus has been awarded funding for their project European Performing Science Night to hold an event within European initiative with the participation of the IGTP.
The seed-funding round for the IGTP Spin-off Time is Brain has reached its financing objective in record time almost as soon as it opened. The company opened the round on the platform Capital Cell and has not only reached the goal of 640,000, but has passed it and received 800,000, the figure the spin-off had set as a maximum.
Mireia Ramos Rodríguez is a bioinformatics post-doctoral researcher; she focusses on defining the changes in cis-regulatory elements that can lead to the development of disease and programming to provide tools for other researchers to carry out their analyses. She has been awarded the Prize for Best Research Paper in Health by a Predoctoral Researcher for her article published in Nature Genetics.
The study focusses on understanding the mechanisms that keep the infection latent without the infected person developing the disease. 90% of people infected never develop the active disease, understanding this mechanism so that we can identify them is key to eradicating tuberculosis. The research has been carried out in virtual lungs, developed by computational modelling techniques. These are the first results to be published by the 3Rs Programme at the Centre for Comparative Medicine and Bioimage (CMCiB) which aims to minimize the use of animals in pre-clinical research.
Last week the preliminary results of a collaboration between the scenic arts and science, or in other words, between the Èpica Foundation of the Fura dels Baus and the IGTP were presented. The workshop and the resulting performance took place last November and now the researchers are processing the data collected from the experience, which will be useful for their respective research projects.
Two groups at the IGTP have taken part in the workshop "Complex Systems" organized by the Èpica Foundation. The experience is a first for the IGTP and has meant that art and science have worked together to produce results for both of them. Èpica is a space for interdisciplinary learning and training for the performing arts run by the Fura dels Baus. The results of the workshop are based on research projects from the IGTP and will be shown this Friday and Saturday 29 and 30 November at the Èpica headquarters in Badalona.
The Neuromuscular and Neuropediatric Group at the IGTP, led by Gisela Nogales-Gadea have identified a subset of patients with an atypical type of myotonic dystrophy type 1 (MD1), which develops later and with more severe symptoms than usual. This has important implications for diagnosis of these patients, who can be misdiagnosed or not given the correct prognosis. It is also vital for managing the disease correctly in patients and their families. The study has been published in Human Mutation.
